A straightforward blood examination will soon be able to diagnose lung cancer, claim scientists.

A global panel, chaired by Dr. Samir Hanash from Seattle's Hutchinson Center, has revealed that it has almost completed the mandatory requirements for developing a revolutionary method capable of detecting lung cancer during its initial stages.

The blood examination will apparently track the disease way ahead of the inception of symptoms. Fabricating a blood test to perceive lung cancer is gradually more within reach, Hanash said.

Earlier, unidentified protein molecules, present in the main bloodstream of patients, were considered as imperative for developing the assessment, which may well turn out to be the most influential substitute to persistent diagnostic approaches. The molecules, which were first tracked in mice, were reportedly similar in case of humans suffering from lung cancer.

The discovery is likely to pioneer not only a blood analysis capable of detecting lung cancer, but it will provide a method distinguishable from other kinds of the ailments.

Dr Hanash further claimed that there is a considerable necessity for an uncomplicated, non-invasive method to timely identify the symptoms of the lethal lung cancer. While imaging-oriented diagnose to track lung cancer proved a bit of worth, blood-oriented screening offered a balancing way to expose, classify and monitoring the development of lung cancer.